Results 101 to 110 of about 32,279 (169)
Regional variations and trends in hemophilia prevalence: A global analysis with future projection. [PDF]
PLOS Glob Public HealthMothashin M +5 more
europepmc +1 more source
Fitusiran treatment modulates the ratio between alpha- and beta-antithrombin isoforms. [PDF]
HemasphereMcCluskey G +10 more
europepmc +1 more source
Development of an Agent-Based Model to Investigate Durability of Factor IX Activity in Hemophilia B Patients Treated With Etranacogene Dezaparvovec. [PDF]
CPT Pharmacometrics Syst PharmacolLi Y +7 more
europepmc +1 more source
An analysis of attitudes toward gene therapy in people with severe hemophilia in Germany, a survey-based cross-sectional study. [PDF]
Ther Adv HematolBabayeva S +7 more
europepmc +1 more source
Acquired Hemophilia A Associated with Post-Essential Thrombocythemia Myelofibrosis: A Rare Autoimmune Bleeding Complication [PDF]
Turk J HaematolKır S, Patır DÇ, Demirci Z, Şahin F.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Emergency Medicine Clinics of North America, 1993
Hemophilia and von Willebrand's disease are the most common hereditary bleeding disorders. A variety of treatment modalities of these disorders are discussed. Common organ system bleeding and its treatment and disposition are outlined. Finally, potential complications of both the disease and treatment are reviewed.
J A, Pfaff, M, Geninatti
openaire +2 more sources
Hemophilia and von Willebrand's disease are the most common hereditary bleeding disorders. A variety of treatment modalities of these disorders are discussed. Common organ system bleeding and its treatment and disposition are outlined. Finally, potential complications of both the disease and treatment are reviewed.
J A, Pfaff, M, Geninatti
openaire +2 more sources
Pediatrics In Review, 1991
Hemophilia is a hereditary bleeding disorder characterized by Factor VIII (F-VIII) or Factor IX (F-IX) deficiency, bleeding into joints and soft tissues, and an X-linked mode of inheritance. Approximately one third of new cases occur as spontaneous mutations, with no family history of hemophilia.
J M, Lusher, I, Warrier
openaire +2 more sources
Hemophilia is a hereditary bleeding disorder characterized by Factor VIII (F-VIII) or Factor IX (F-IX) deficiency, bleeding into joints and soft tissues, and an X-linked mode of inheritance. Approximately one third of new cases occur as spontaneous mutations, with no family history of hemophilia.
J M, Lusher, I, Warrier
openaire +2 more sources
A Challenge for Hemophilia Treatment: Hemophilia and Cancer
Journal of Pediatric Hematology/Oncology, 2020Background: The risk of developing cancer increases with age and also adverse environmental conditions. The same holds true in the aging people with hemophilia (PwH). Furthermore, cancer is an important challenge for physicians working in multidisciplinary hemophilia care centers. Aim:
Basak, Koc, Bulent, Zulfikar
openaire +2 more sources